Sage Capital Advisors’s Gilead Sciences GILD Stock Holding History

Sage Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,400	Closed	-$263K	–	88
2018 Q3	$263K	Hold	3,400	–	–	0.16%	78
2018 Q2	$241K	Hold	3,400	–	–	0.17%	75
2018 Q1	$256K	Hold	3,400	–	–	0.18%	72
2017 Q4	$244K	Hold	3,400	–	–	0.16%	74
2017 Q3	$275K	Buy	+3,400	New	+$260K	0.19%	71

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sage Capital Advisors's GILD Position: Q4 2018 in Review

Sage Capital Advisors sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,400 shares — an estimated $263K sold.

Sage Capital Advisors first reported a position in GILD in Q3 2017 and held it in 5 quarters. The position peaked at $275K in Q3 2017. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Sage Capital Advisors reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Sage Capital Advisors sold 3,400 Gilead Sciences shares in Q4 2018, an estimated $263K.
Sage Capital Advisors first reported a position in Gilead Sciences in Q3 2017 and held it in 5 quarters.
Sage Capital Advisors's Gilead Sciences position peaked at $275K in Q3 2017.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Sage Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.